Propylene Glycol Allergy: When Your Medication's Vehicle Is the Problem
Propylene glycol is a humectant and solvent found in cosmetics, medications, and foods that was named ACDS Allergen of the Year in 2018. It causes both irritant and — less commonly — true Type IV allergic contact dermatitis, making diagnosis tricky. The critical paradox: it appears in 64% of topical corticosteroid formulations, meaning the vehicle can worsen the skin condition being treated. Avoidance and accurate patch testing are the cornerstones of management.
Free · 5 min · Insurance accepted
Key facts
Propylene glycol was named ACDS Allergen of the Year 2018; it appears in approximately 64% of topical corticosteroid formulations — the vehicle can worsen the skin condition being treated.
NACDG patch testing with 30% aqueous propylene glycol shows approximately 3.5% positivity — but distinguishing true Type IV contact allergy from irritant reactions requires careful concentration testing.
North American Contact Dermatitis Group, Dermatitis, 2017–2022
Propylene glycol (PG) appears under 20+ ingredient names across cosmetics, medications, and foods — successful avoidance requires recognizing all aliases on product labels.
American Contact Dermatitis Society, Allergen of the Year 2018
Propylene glycol can cause both irritant contact dermatitis (dose-dependent, no sensitization required at >30% aqueous) and true allergic contact dermatitis — the mechanism determines management (avoidance vs. elimination trial)
PG-free topical corticosteroid formulations exist for all potency classes — prescribing the correct vehicle after confirming PG allergy resolves the paradox of steroid creams worsening eczema in ~3.5% of tested patients
What Is Propylene Glycol and Why Does It Cause Reactions?
Propylene glycol (PG) is a small, colorless, water-miscible organic compound used as a humectant, solvent, and preservative across thousands of products — from moisturizers and topical medications to injectable drug formulations, food flavorings, and even aircraft de-icing fluids.
Its chemical simplicity and excellent solubilizing properties make it nearly ubiquitous in pharmaceutical and personal care formulations.
The core challenge with propylene glycol is mechanistic ambiguity. Unlike most contact allergens, PG produces reactions through two distinct pathways: irritant contact dermatitis (more common) and true Type IV delayed hypersensitivity (less common but clinically significant). At high concentrations — typically above 10% in formulations — PG disrupts the skin barrier directly, producing irritant reactions that look identical to allergic contact dermatitis on clinical exam and can even mimic it on patch testing. This overlap makes definitive diagnosis extraordinarily difficult.
The ACDS named propylene glycol its Allergen of the Year in 2018 precisely to highlight this challenge and its underrecognized clinical impact. Dermatologists and allergists need to consider PG when patients continue to worsen on topical therapies, particularly corticosteroids, since PG appears in a substantial majority of these formulations as a vehicle ingredient. When the vehicle is the culprit, applying more medication only perpetuates the reaction — a frustrating clinical trap that this page aims to help patients and providers recognize.
Symptoms of Propylene Glycol Sensitivity
Recognizing symptoms early helps you get the right treatment faster.
Contact dermatitis at application site
moderateRed, itchy, scaly, or vesicular skin eruption appearing 12-96 hours after contact with a PG-containing product. Most commonly affects the face, hands, or body areas where products are applied.
Burning or stinging on application
mildAn immediate stinging sensation when applying PG-containing products can occur with both irritant and allergic mechanisms, though immediate reactions suggest irritation more than allergy.
Chronic hand eczema
moderatePersistent eczema on the hands, sometimes mistaken for pompholyx or other forms of hand dermatitis, can reflect ongoing PG exposure through topical medications, hand lotions, or occupational products.
Facial dermatitis
moderateRedness, scaling, and itching on the face from PG-containing moisturizers, makeup, or topical medications; may be misattributed to rosacea or seborrheic dermatitis.
Eyelid dermatitis
moderateThe thin skin of the eyelids is highly sensitive; PG in eye creams, makeup remover, or eye drops can cause swelling, redness, and itching in this area.
Generalized eczematous eruption (systemic form)
severeIn patients sensitized through skin contact, oral ingestion of PG in food or liquid medications can trigger a widespread, symmetrical eczematous flare — a systemic contact dermatitis presentation.
Treatment-resistant worsening dermatitis
moderateA characteristic clinical signal: eczema that fails to respond to topical corticosteroids, or actually worsens with their use, because the corticosteroid's PG vehicle is perpetuating the reaction.
Rare urticaria or anaphylaxis
severeTrue immediate IgE-mediated reactions to PG are extremely rare; however, case reports of urticaria and anaphylaxis from parenteral PG exposure exist. Seek emergency care if hives, facial swelling, or breathing difficulty develop.
When to see a doctor
Symptoms of propylene glycol reactions range from mild localized skin irritation to widespread eczematous dermatitis. The most common presentation is contact dermatitis at sites of direct product application — face, hands, or body areas where topical medications or cosmetics are used. Because PG is in so many different product types, reactions can appear on almost any body surface. A clinical hallmark is that symptoms may not improve — and can worsen — despite ongoing use of topical corticosteroid therapy, because the PG vehicle in the corticosteroid formulation perpetuates the reaction. This pattern of treatment-resistant dermatitis is a key clinical signal. In systemic contact dermatitis from oral PG exposure, the reaction is more diffuse: generalized eczema, hand dermatitis, and symmetrically distributed skin eruptions without a clear topical exposure pattern. This form is rarer but can be disabling. Seek medical evaluation promptly if skin reactions are worsening despite appropriate treatment, if you develop facial swelling or difficulty breathing after using a product containing PG, or if dermatitis is extensive and affecting your daily life.
Propylene Glycol and Respiratory Symptoms
Propylene glycol is used as a carrier in some nebulizer solutions and inhaled medications, and it is a common ingredient in e-cigarette liquids and theatrical fog machines. Inhalation of aerosolized PG can cause respiratory irritation — coughing, throat irritation, and mild bronchospasm — in susceptible individuals, particularly those with pre-existing asthma. This is primarily an irritant effect rather than a true IgE-mediated allergy. Occupational exposure in the theatrical and nightclub industry has been documented: performers and stage crew exposed to PG-based fog machines over long periods have reported increased asthma-like symptoms. Similarly, some patients with reactive airway disease report worsening when using PG-containing nebulizer solutions. If you have asthma and notice respiratory symptoms correlating with PG-containing inhaled products or environmental fog, discussing this pattern with your physician is worthwhile. Switching to PG-free nebulizer diluents or avoiding theatrical fog exposure may reduce symptoms.
Complications of Unrecognized Propylene Glycol Sensitivity
When propylene glycol sensitivity goes unrecognized, the consequences extend beyond skin discomfort. The most common complication is a cycle of treatment failure: topical corticosteroids are prescribed for dermatitis, the PG in the vehicle worsens the dermatitis, the dose is increased, and the skin deteriorates further. Patients may undergo multiple treatment courses, specialist referrals, and even oral immunosuppression before PG is identified as the culprit — a costly and distressing diagnostic odyssey. Chronic untreated contact dermatitis can lead to thickened, lichenified skin (chronic eczema with skin thickening), secondary bacterial infection from repeated scratching, post-inflammatory hyperpigmentation, and significant quality-of-life impairment including sleep disruption and occupational difficulty. In the systemic form, patients may need to scrutinize food labels and oral medication ingredients — a significant lifestyle burden. A delayed diagnosis can also contribute to unnecessary restriction of other products. Patients sometimes avoid multiple topical treatments (incorrectly attributing reactions to the active medication rather than the vehicle), potentially delaying effective therapy for the underlying condition.
Treatment-failure cycle
Continued use of PG-containing corticosteroids worsens the skin reaction, leading to escalating treatment and delayed diagnosis of PG as the underlying cause.
Secondary bacterial infection
Broken, chronically inflamed skin from untreated contact dermatitis provides an entry point for Staphylococcus aureus and other pathogens.
Chronic lichenification
Repeated scratching and inflammation thickens the skin over time, creating a self-perpetuating itch-scratch cycle that can persist even after the original trigger is removed.
Systemic contact dermatitis
In patients with PG sensitization, oral ingestion of PG-containing foods or medications can trigger widespread eczematous eruptions throughout the body, not just at contact sites.
Occupational impact
Healthcare workers and cosmetologists who cannot avoid PG in their work environment may face significant occupational limitations or need workplace accommodations.
Sources of Exposure and Why Reactions Develop
Propylene glycol exposure is nearly unavoidable in modern life because it functions as a versatile ingredient across multiple product categories. In skin care and cosmetics, PG appears in moisturizers, cleansers, shampoos, conditioners, makeup, sunscreens, and deodorants. In pharmaceutical products, it is a solvent vehicle in topical preparations (creams, ointments, gels), injectable medications, and oral liquid formulations. In food, it is listed as GRAS (Generally Recognized as Safe) by the FDA and used as a humectant and flavor carrier in baked goods, salad dressings, and processed foods.
How it works
Propylene glycol causes two distinct reactions. In irritant contact dermatitis, PG at concentrations above roughly 10% disrupts skin barrier lipids directly, without immune involvement. In true allergic contact dermatitis, PG acts as a hapten, binding to carrier proteins in the skin to form an immunogenic complex that sensitizes CD4+ and CD8+ T lymphocytes. Upon re-exposure, these sensitized T cells release cytokines — interferon-gamma, TNF-alpha, interleukin-17 — producing the characteristic delayed (48-96 hour) inflammatory response of Type IV hypersensitivity. Both mechanisms can coexist, complicating patch test interpretation.
The sensitization route is primarily cutaneous. Prolonged or repeated exposure to PG in leave-on products — particularly under occlusive conditions such as under bandages or skin folds — increases sensitization risk. Once sensitized, subsequent exposure to any PG-containing product can trigger a reaction, regardless of product type.
Systemic contact dermatitis is a particularly challenging manifestation: a patient sensitized through skin contact can later experience a widespread eczematous flare when ingesting PG orally (in food or liquid oral medications). Oral provocation testing with escalating doses is considered the most definitive test for this systemic form, though it is performed only in specialized clinical settings under medical supervision.
Risk factors to watch for
Frequent use of leave-on topical medications
Patients using topical corticosteroids or emollients daily — especially under occlusion — have sustained, high-dose skin exposure that increases sensitization risk.
Atopic dermatitis
Atopic individuals have a compromised skin barrier that allows higher PG penetration, increasing both irritant reactions and sensitization risk.
Occupational exposure
Healthcare workers, food handlers, and cosmetologists encounter PG in disinfectants, injectable preparations, and cosmetic products at higher frequencies than the general public.
High PG concentration in formulations
Formulations containing PG at concentrations above 5-10% (common in some gels and injectable vehicles) are more likely to produce both irritant and allergic reactions.
Oral exposure in sensitized individuals
Patients already contact-sensitized to PG can develop systemic contact dermatitis when PG is consumed orally — through food or liquid oral medications — even at low concentrations.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
How Propylene Glycol Sensitivity Is Diagnosed
Diagnosing propylene glycol sensitivity is one of dermatology's more challenging problems because of the irritant-versus-allergic ambiguity. The gold standard is patch testing performed by a board-certified dermatologist or allergist specializing in contact dermatitis. The NACDG standard is propylene glycol at 30% in aqueous solution applied under occlusion for 48 hours. The critical distinction between irritant and allergic reactions depends on the reading time and morphology: allergic reactions show a crescendo pattern (intensifying or persisting at 72-96 hours), while irritant reactions typically fade. A Day 7 reading can further clarify ambiguous cases. Careful clinical correlation — asking whether the reaction distribution matches product exposure patterns — is essential, because even a positive patch test to PG must be interpreted in clinical context. For suspected systemic contact dermatitis, oral provocation testing under physician supervision is the most definitive approach. The patient ingests escalating oral doses of propylene glycol and is monitored for cutaneous or systemic reactions. This testing is typically done in specialized contact dermatitis clinics. A thorough product inventory is invaluable. Your dermatologist will typically ask you to bring all topical products you use regularly — including prescription medications, OTC creams, cosmetics, and personal hygiene products. Cross-referencing ingredient labels for PG (also listed as 1,2-propanediol or propane-1,2-diol) often identifies the exposure source before formal testing. For patients who want to understand their broader allergen profile alongside contact testing, at-home allergen testing services such as Curex offer IgE-based panels covering 40+ common environmental, food, and respiratory allergens — a convenient complement to in-clinic patch testing when both contact and IgE-mediated sensitivities are a concern.
Patch Test (30% aqueous)
Propylene glycol at 30% aqueous is applied under occlusion for 48 hours, with readings at 48 and 72-96 hours. A crescendo pattern (intensifying reaction) suggests true allergic contact dermatitis. Considered the diagnostic gold standard for PG contact allergy.
Repeat Open Application Test (ROAT)
The patient applies a diluted preparation of the suspected product to the forearm twice daily for up to 7 days and monitors for reaction. Useful for confirming relevance of a positive patch test in a real-world application context.
Oral Provocation Testing
Performed under physician supervision in specialized settings, escalating oral doses of PG are ingested to identify systemic contact dermatitis. This is the only definitive test for the oral/systemic sensitization route.
Product Ingredient Review
Systematic review of all topical products and oral medications for PG content (listed as propylene glycol, 1,2-propanediol, or propane-1,2-diol). Often identifies the culprit product before formal testing.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
Subcutaneous and sublingual allergen immunotherapy are established treatments for IgE-mediated allergies — respiratory allergens, stinging insect venom, and food allergies. However, propylene glycol sensitivity is a Type IV cell-mediated contact allergy (or an irritant reaction), not an IgE-mediated condition. As a result, conventional allergen immunotherapy is not an established or recommended treatment for PG contact dermatitis. The primary management strategy remains avoidance and skin barrier repair, not immune desensitization. There is no approved SCIT or SLIT protocol for propylene glycol contact allergy. For patients who also have co-existing IgE-mediated allergies — such as environmental allergens (dust mites, pollens, pet dander) that contribute to overall inflammation and atopic skin barrier dysfunction — immunotherapy for those allergens may indirectly benefit skin health. Sublingual immunotherapy, offered by providers like Curex, delivers custom-formulated allergen drops under the tongue and can be taken at home, eliminating weekly clinic visits required for allergy shots. Plans typically start at $39/month and are covered by most insurance. However, this addresses co-existing IgE-mediated allergies, not the PG contact sensitization itself. If you have both contact allergy to PG and confirmed IgE-mediated allergies, a board-certified allergist can help you prioritize which conditions to address through immunotherapy.
Confirm PG allergy via patch testing
A board-certified dermatologist performs patch testing to confirm true Type IV sensitization to PG versus irritant reaction.
Comprehensive product audit
Systematically identify and replace all PG-containing products across skincare, medications, and food where possible.
Evaluate co-existing IgE allergies
If respiratory or food allergies also contribute to atopic skin conditions, a separate evaluation for IgE-mediated allergy determines immunotherapy candidacy.
Ongoing monitoring
Regular follow-up with a dermatologist to assess skin improvement after avoidance measures and to address any new exposures.
“Evidence suggests that strict, confirmed PG avoidance leads to significant improvement or resolution of contact dermatitis in the majority of affected patients, though reexposure through hidden sources can cause recurrence.”
Treat your Propylene Glycol allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living With Propylene Glycol Sensitivity
Managing a propylene glycol sensitivity requires ongoing vigilance but is very achievable with the right strategies. Once patients identify and eliminate their PG exposures, most experience significant improvement in skin health and quality of life. The initial adjustment period — auditing products, finding replacements, informing healthcare providers — takes time and effort, but eventually becomes routine. The most common ongoing challenge is managing new exposures from new products or medications. It helps to have a personal protocol: any time a new skincare product, medication, or personal care item is introduced, check for PG before use. A small test patch on an inconspicuous area of skin with new topical products can identify reactions before widespread application. Emotional impact is real: patients often feel frustrated when a reaction occurs despite careful label-reading, or when a dermatitis flare interrupts work or social activities. Online communities for contact allergy patients and the American Contact Dermatitis Society (ACDS) resources can provide peer support and practical product recommendations.
Building a PG-free medicine cabinet
Work with your pharmacist to identify PG-free versions of every topical and oral liquid medication you use regularly. Keep a printed reference card for healthcare visits so new prescriptions are always checked.
Managing reactions when they occur
When a reaction develops despite precautions, immediately discontinue the offending product, apply a thin layer of plain petrolatum to the affected area, and contact your dermatologist if the reaction is severe or spreading.
Communicating with healthcare providers
Before any procedure, hospital admission, or new prescription, specifically mention your propylene glycol sensitivity. Many topical antiseptics, wound care preparations, and IV medication diluents contain PG and substitutes should be requested proactively.
Travel and PG sensitivity
When traveling, bring your confirmed-safe products rather than relying on hotel toiletries, which commonly contain propylene glycol. Carry a card listing your sensitivity in the local language when traveling internationally.
Seasonal Patterns
January - December
medium intensity
Prevention Tips
Learn all PG ingredient names
Recognize propylene glycol, 1,2-propanediol, and propane-1,2-diol on labels to catch all exposures across product types.
Switch to ointment-based topical medications
Ointment formulations (petrolatum base) are more likely to be PG-free than creams or gels; ask your dermatologist for ointment alternatives.
Use the FDA Inactive Ingredients Database
Before starting any new oral liquid medication or injectable drug, check the FDA database or ask your pharmacist to verify PG content.
Keep a confirmed-safe product list
Maintain a running list of products you've verified as PG-free to streamline future purchases and reduce the burden of repeated label reading.
Notify all healthcare providers
Alert every physician, nurse, and pharmacist to your PG sensitivity so it can be flagged during medication reconciliation and before any procedure involving topical anesthetics or cleansing agents.
Be cautious with new 'natural' products
Propylene glycol is used in some natural and organic formulations as well as conventional ones; do not assume a product is PG-free based on marketing claims alone.
Prognosis and Long-Term Outlook
The prognosis for propylene glycol sensitivity is generally favorable once the diagnosis is established and exposure is controlled. Unlike some contact allergens that are nearly impossible to avoid, PG-free alternatives exist across virtually every product category — cosmetics, medications, personal care items, and food — making successful long-term avoidance realistic for most patients. True contact allergy to PG typically persists for life; sensitization does not resolve spontaneously in most patients. However, with strict avoidance, patients can remain entirely symptom-free. The challenge is detecting hidden exposures — particularly in new products or new formulations of previously safe products, since manufacturers change ingredient lists. For patients whose PG sensitivity involves the systemic form, the management is more complex and quality of life impact is higher, but even this form is manageable with dietary guidance and careful medication review. Regular follow-up with a contact dermatitis specialist is recommended annually or whenever unexplained flares occur.
Key takeaways
True PG allergy persists lifelong, but symptoms are completely controllable with diligent avoidance
Most patients achieve clear skin within 4-8 weeks of eliminating all PG-containing products
The critical clinical trap — worsening with topical corticosteroid use — resolves as soon as PG-containing formulations are switched to PG-free ointments
Regular communication with all healthcare providers about PG sensitivity prevents inadvertent reexposure through prescribed medications
Dietary Propylene Glycol and Systemic Contact Dermatitis
Propylene glycol is a GRAS (Generally Recognized as Safe) food additive in the United States, used as a humectant and solvent in a range of processed foods including baked goods, salad dressings, ice cream, and some flavor extracts. For most people, dietary PG poses no concern. However, individuals with confirmed systemic contact dermatitis from PG sensitization may experience widespread eczematous flares following oral PG ingestion. Identifying and reducing dietary PG is challenging because food labels may list it as propylene glycol or E1520 but it is not always prominently disclosed. Foods most commonly containing PG include commercially packaged baked goods, cake mixes, salad dressings, some ice creams, and flavored coffees. Oral provocation testing under physician supervision is the definitive way to confirm whether dietary PG is contributing to systemic reactions. A low-PG diet, guided by a dietitian, may reduce the frequency of systemic flares in confirmed cases — but should be undertaken with professional guidance rather than wholesale elimination of food groups.
Foods to limit
Packaged baked goods and cake mixes
Commonly contain propylene glycol as a humectant to maintain moisture
Bottled salad dressings
May use PG as a solvent and emulsifier in many commercial formulations
Some flavored coffee syrups and extracts
Propylene glycol is used as a flavor carrier in many artificial and natural flavor extracts
Commercial ice cream and frozen desserts
PG may be used to improve texture and prevent ice crystal formation
Propylene glycol is the classic 'vehicle problem' — a patient whose eczema gets worse every time they apply their prescribed steroid cream often has PG allergy to the cream base rather than a treatment-resistant form of their condition; patch testing with 30% aqueous PG is the diagnostic step that unlocks the problem.
Frequently Asked Questions
The most common symptom is contact dermatitis — red, itchy, scaly, or blistering skin at the site where a PG-containing product was applied. This typically appears 12 to 96 hours after contact, consistent with a Type IV delayed hypersensitivity reaction. Less commonly, burning or stinging on application may occur immediately, which usually reflects irritant rather than allergic mechanism. In patients who have systemic contact dermatitis, oral PG ingestion through food or medications can trigger widespread eczematous eruptions beyond the original contact site. Consult a dermatologist if skin reactions persist despite changing products.
These terms are sometimes used interchangeably but have distinct meanings. True propylene glycol allergy refers to immune-mediated Type IV contact hypersensitivity, confirmed by patch testing showing a crescendo-pattern positive reaction. Propylene glycol intolerance or irritant reaction describes non-immune skin barrier disruption from high-concentration PG, which can look identical clinically but does not involve T-cell sensitization. The distinction matters because true allergy requires lifelong avoidance of even trace PG, while irritant reactions may be concentration-dependent and tolerated at lower PG levels. Patch testing by a dermatologist is the only reliable way to make this distinction.
Propylene glycol is an excellent pharmaceutical vehicle — it enhances drug penetration through the skin barrier, keeps formulations stable, and provides a smooth application texture. These properties made it a natural choice for cream-based topical steroid formulations before the clinical significance of PG sensitization was fully appreciated. The ACDS named PG its 2018 Allergen of the Year in part to highlight that it appears in approximately 64% of topical corticosteroid formulations. Many topical corticosteroids are available in ointment formulations that use petrolatum as the vehicle and do not contain PG — ask your dermatologist specifically for a PG-free formulation.
Diagnosis relies on patch testing with propylene glycol at 30% in aqueous solution, applied under occlusion for 48 hours with readings at 48 and 72-96 hours. Allergic reactions show a crescendo pattern — intensifying over time — while irritant reactions fade. The critical challenge is that PG has a high irritant rate at 30%, making interpretation difficult and requiring specialist expertise. For systemic contact dermatitis, oral provocation testing under physician supervision is the definitive diagnostic approach. A detailed product inventory identifying all PG-containing items the patient uses is an essential complement to formal testing.
Yes, propylene glycol sensitization can develop at any age, particularly with sustained exposure through topical medications or cosmetics. Adults who use leave-on skincare products, topical corticosteroids, or medications with PG vehicles daily are at ongoing sensitization risk. Healthcare workers and cosmetologists with regular occupational PG exposure also develop late-onset sensitization. There is no age at which new sensitization cannot occur, though most cases are diagnosed in adults because they involve products used over many years. Children who use topical corticosteroids chronically for atopic dermatitis may also become sensitized to PG in those formulations.
In the US, propylene glycol (also listed as E1520 in international labeling) is GRAS and used in a range of processed foods as a humectant and solvent. Foods commonly containing PG include commercially packaged baked goods, cake mixes, bottled salad dressings, some ice creams, certain cheeses, artificial flavor extracts, and flavored syrups. For most people with contact allergy to PG, dietary amounts are tolerable. However, individuals with confirmed systemic contact dermatitis from oral PG may need to minimize these foods under guidance from a dietitian and their dermatologist. Oral provocation testing is the definitive way to confirm whether dietary PG is triggering systemic skin reactions.
Propylene glycol is used as a solvent in some injectable medications. For individuals with documented PG contact allergy, exposure through injectable routes is a clinical concern, although injected PG reactions are distinct from topical contact allergy. If you have confirmed PG allergy and require injectable medications that contain PG (such as certain intravenous formulations of lorazepam or phenytoin), your healthcare team should be informed so that PG-free alternatives can be selected where available. This is an important safety communication point to include in your medical records and to raise proactively with any prescribing physician or anesthesiologist before procedures.
Both propylene glycol and benzyl alcohol are preservative-solvents used in topical and injectable products, and both have been named ACDS Allergens of the Year (PG in 2018, benzyl alcohol in 2026). However, their clinical profiles differ significantly. Propylene glycol allergy is particularly relevant in topical corticosteroid vehicles — its irritant-versus-allergic ambiguity and presence in 64% of topical corticosteroids are the defining features. Benzyl alcohol allergy, while rarer at a 0.3% positive patch test rate, is especially significant in the injectable medication context (bacteriostatic saline, propofol, lorazepam) and carries a toxicological concern (neonatal gasping syndrome) distinct from contact allergy.
No. Conventional allergen immunotherapy — whether sublingual drops or allergy shots — is designed for IgE-mediated allergies such as pollen, dust mites, or pet dander, not for Type IV contact sensitization. Propylene glycol causes contact dermatitis through a T-cell-mediated mechanism (or direct irritation), not IgE antibodies, so SLIT and SCIT protocols do not apply. If you have co-existing IgE-mediated allergies alongside PG contact sensitivity, immunotherapy can address the IgE-mediated conditions. The treatment for PG contact allergy itself remains strict avoidance and skin barrier repair.
Most patients notice meaningful skin improvement within 2 to 4 weeks of completely eliminating all PG-containing products. Full resolution of established contact dermatitis can take 4 to 8 weeks, depending on the severity and duration of the reaction. The most common reason for slow improvement is incomplete avoidance — a hidden PG source in an unsuspected product that has not been identified and removed. If skin is not improving as expected within 4-6 weeks of apparent PG elimination, returning to your dermatologist for a review of potential remaining exposure sources is recommended.
Medical References
- [1]Warshaw EM, et al. Propylene glycol as a cause of allergic contact dermatitis. Dermatitis. 2018. ACDS Allergen of the Year 2018.
- [2]North American Contact Dermatitis Group (NACDG). Patch testing results with propylene glycol 30% aqueous: 3.5% positive rate. Published in Dermatitis (2017-2022 cycles).
- [3]Toholka R, et al. Frequency of propylene glycol in topical corticosteroid formulations. Contact Dermatitis. Approx. 64% prevalence noted in US corticosteroid preparations.
- [4]Zug KA, et al. Patch testing North American contact dermatitis group data. Dermatitis. Multiple cycles demonstrating PG sensitization patterns.
- [5]Jacob SE, Scheman A, McGowan MA. Propylene glycol. Dermatitis. 2018;29(1):3-5. ACDS Allergen of the Year review.
- [6]American Contact Dermatitis Society (ACDS). Allergen of the Year announcements. ACDS official website.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Propylene Glycol allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.